● TIER 1 — FDA-approved / recognizedGRADE A (obstetric) / B (intranasal)Sexual health
Oxytocin
Neurohypophyseal hormone. Research verification: Yes (TGA pending). 1 human study record(s) in the FitClinicMD studies database.
GOALS · Sexual function
FDA status
Approved: Pitocin (IV obstetric). Intranasal not approved in US.
Compounding (503A/503B)
Approved product.
DEA
Not controlled.
WADA (sport)
Not listed on 2026 Prohibited List (no matching section found)
Mechanism
OXTR agonist.
Human evidence · 1
Intranasal, n=290 children/adolescents with ASD: no benefit. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
Reference only. This page summarizes publicly available regulatory and research information about Oxytocin. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.